In this episode, Lisa Jones interviews Jennifer Smith, RD, LD, CDCES, and Susan Weiner, MS, RDN, CDN, CDCES, FADCES, about diabetes technology, including smartphone applications, and making recommendations to clients and patients to fit their individual needs. This is episode 1 of a 4-part series.
A new era of long-acting antiretrovirals for HIV treatment and prevention demands a nonlinear approach to global access with faster sharing of technology, decentralized production,…
Originally posted on Common Sense Family Doctor on March 30, 2022.
The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.
Researchers from Mass General Brigham, a health care system in Boston, Massachusetts, shared with Fox News Digital some of the scientific developments and breakthroughs they…
The addition of zolbetuximab, an anti–claudin 18.2 antibody, to chemotherapy in gastric and gastroesophageal junction adenocarcinoma led to longer progression-free and overall survival than chemoth…
In the NEJM Journal Watch General Medicine annual review of important clinical research — most of which was summarized in NEJM Journal Watch General
In this analysis, baseline peanut sIgE was shown to be a stronger predictor of remission after peanut OIT than age at the beginning of immunotherapy…
Intralesional injections of triamcinolone acetonide are widely used to treat nail psoriasis and other inflammatory nail conditions. But information on optimal dosing has been largely…
For the first time, a randomized trial has found a surgical intervention to be superior to standard medical therapy for supratentorial intracerebral hemorrhage.
What We’re Showing The change in market value of the six biggest tech companies since ChatGPT was launched in November 2022. The data comes from…
